The luteal phase defect: the relative frequency of, and encouraging response to, treatment with vaginal progesterone

Fertility and Sterility, 34(1), 17-20

DOI 10.1016/s0015-0282(16)44831-4 PMID 7398902

Abstract

Three hundred and ninety-six patients were evaluated for primary and secondary infertility between December 1976 and May 1979 at a large referral center. Timed late luteal endometrial biopsies were routinely obtained as part of the work-up and were repeated for confirmation if subsequent menses did not occur within 2 days of the expected date. If both biopsies were abnormal, a diagnosis of luteal phase defect (LPD) was made and patients were treated with vaginal progesterone suppositories for a minimum of 6 months. LPD was discovered in 32 of 396 patients (8.1%); among those patients whose infertility was not complicated by other abnormalities, 9 of 13 conceived (70%) and 7 of 13 carried to term (54%). These data suggest an incidence higher than generally recognized and a very encouraging response to replacement therapy.

Topics

luteal phase defect vaginal progesterone treatment, progesterone suppositories luteal phase deficiency infertility, endometrial biopsy luteal phase defect incidence, luteal phase defect frequency infertility population, Rosenberg vaginal progesterone luteal phase defect, progesterone replacement therapy recurrent pregnancy loss, late luteal endometrial biopsy infertility workup, luteal phase defect conception rate treatment outcome, primary secondary infertility luteal phase evaluation, timed endometrial biopsy luteal phase dating confirmation
PMID 7398902 7398902 DOI 10.1016/s0015-0282(16)44831-4 10.1016/s0015-0282(16)44831-4

Cite this article

Rosenberg, S. M., Luciano, A. A., & Riddick, D. H. (1980). The luteal phase defect: the relative frequency of, and encouraging response to, treatment with vaginal progesterone. *Fertility and sterility*, *34*(1), 17-20. https://doi.org/10.1016/s0015-0282(16)44831-4

Related articles